30 Apr Q&A: Creating value through IP asset management and valuation for the Biotechnology industry
We are excited to kick off our series of online Q&A conversations. Join us and hear from leading industry experts, as they cover a wide range of topics relevant for emerging life science companies.
In this first event, BaseLaunch moderates a discussion on creating value through IP asset management and valuation for the Biotechnology industry. The Q&A will be between Philipp Marchand at Vossius & Partner and entrepreneurs and founders of life science companies in the audience.
When: 13.05.2020, 14:00 – 15:00
Where: Zoom webinar, link upon registration
Leonildo Delgado, BaseLaunch
Philipp Marchand, Vossius & Partner
Participation to the event is free of charge; however, your registration by 12.05.2020 is kindly required.
About the speaker
Dr. Philipp Marchand joined Vossius & Partner in 2012 after graduating in biochemistry at the University in Frankfurt am Main and completing his PhD studies at a CNRS institute in Paris. He joined the Swiss office of Vossius & Partner in Basel in 2017 and became a partner of the firm in 2020. He focuses on strategic portfolio and value generation for startup companies. At the same time, he provides portfolio and risk assessments for venture capitalists and startup investors.
Dr. Marchand is the exclusive IP partner of BaseLaunch. Moreover, he has been accredited with the Swiss government as an Innosuisse Special Coach for IP. He currently works on his doctoral degree in law at the University of Basel where he investigates the applicability of copyright law in biotechnology.
Vossius & Partner is a leading patent law firm offering a full-service concept with legal competence from patent attorneys in every technological sector and attorneys-at-law qualified to practice not only in Europe and Switzerland, but also in the United States, Japan, Taiwan, China and Korea. The firm employs 55 patent attorneys and 20 attorneys-at-law in their offices in Munich, Düsseldorf, Berlin and Basel.